Laviolette Paul A
SEC-identified person · CIK 1191249 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Pulse Biosciences, Inc. PLSE | Director · Chief Executive Officer | filed 2024 - 2026 |
| Edwards Lifesciences Corp ew | Director | filed 2020 - 2026 |
| Misonix INC MSON | Director | filed 2019 - 2021 |
| Transenterix, INC. TRXC.OB | Director | filed 2013 - 2021 |
| Thoratec Corp THOR | Director | filed 2009 - 2015 |
| Trans1 INC [BAXS] | Director | filed 2008 - 2014 |
| Conceptus INC CPTS | Director | filed 2009 - 2013 |
| Boston Scientific Corp bsx | COO | filed 2007 - 2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.